Turnstone Biologics
2015
FOUNDED
PRIVATE
STATUS
21-30
EMPLOYEES
Series C
LATEST DEAL TYPE
$42.1M
LATEST DEAL AMOUNT
4
INVESTORS
Description
Developer of viral immunotherapies designed to improve survival for patients with cancer. The company's immunotherapies combine a bio-selected and engineered oncolytic virus to directly lyse tumors with a potent vaccine technology to drive tumor-antigen specific T-cell responses, enabling bio-medical professionals to generate immune responses, treat cancer and modulate tumor environment.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Primary Office
- 787 Bank Street
- 2nd Floor
- Ottawa, Ontario K1S 3V5
- Canada
+1 (613) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Turnstone Biologics’s full profile, request a free trial.
Turnstone Biologics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series C) | 04-Jan-2019 | $42.1M | 000.00 | Completed | Generating Revenue | |
| 3. Early Stage VC (Series B) | 02-Nov-2016 | 000.00 | 000.00 | Completed | Generating Revenue | |
| 2. Early Stage VC (Series A) | 28-Oct-2015 | $11.3M | $11.3M | Completed | Startup | |
| 1. Angel (individual) | 04-May-2015 | Completed | Startup |
Turnstone Biologics Competitors (26)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| DNAtrix | Venture Capital-Backed | Houston, TX | 00 | 000.00 | 00000000000 | 000.00 |
| 000000 | Angel-Backed | Lyon, France | 00 | 00.000 | 0000000000 | 00.000 |
| 000000 | Venture Capital-Backed | Seattle, WA | 00 | 000.00 | 0000000000 0 | 000.00 |
| 000000 00000000000 | Failed Transaction (M&A) | Cambridge, MA | 000 | 00000 | 000000&0 | |
| 00000000 | Corporate Backed or Acquired | Seal Beach, CA | 000 | 00.000 | 000000&0 |
Turnstone Biologics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| F-Prime Capital Partners | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| OrbiMed | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Versant Venture Management | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Fight Against Cancer Innovation Trust | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |
Turnstone Biologics Executive Team (12)
1 Former Executive
You’re viewing 5 of 12 executives. Get the full list »Turnstone Biologics Board Members (9)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Ben Auspitz | F-Prime Capital Partners | Board Member | 000 0000 | |
| Bradley Bolzon Ph.D | Versant Venture Management | Board Member | 000 0000 | |
| Jeff Courtney | Fight Against Cancer Innovation Trust | Board Member | 000 0000 | |
| Jerel Davis Ph.D | Versant Venture Management | Board Member | 000 0000 | |
| Patrick Machado JD | Self | Board Member | 000 0000 |